ArticleVaccine2022

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.

Takuya Hemmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.